Eduardo R. H.
- Country
- Spain
- Department
- Hematology
Research Overview
- Phase 2 Study on Epcoritamab Monotherapy or Combined with Lenalidomide for Anthracycline-Ineligible Diffuse Large B-Cell Lymphoma Patients
- A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1)
- Phase 3 Randomized Study of Pirtobrutinib vs. Bendamustine and Rituximab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Data & Insights
Has run more than one trial at 147 of 337 partner sites.
Specializations
Chronic Lymphocytic Leukemia Research
The investigator specializes in developing therapeutic approaches for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), with particular focus on novel treatment combinations and strategies.
- Fixed-duration versus MRD-guided therapy evaluation
- Novel agent combinations with venetoclax
- BTK inhibitor-based treatments
Research interests include exploring targeted therapies such as pirtobrutinib, zanubrutinib, and obinutuzumab in various therapeutic combinations.
B-Cell Lymphoma Studies
Focused on advancing treatment options for diffuse large B-cell lymphoma (DLBCL), investigating innovative therapeutic approaches and combinations.
- Epcoritamab-based therapy evaluation
- Combination strategies with lenalidomide
- Novel immunotherapy approaches
Areas of investigation include first-line treatments and comparative studies with standard-of-care chemotherapy regimens.
Follicular Lymphoma Investigation
Conducting research in follicular lymphoma treatment, with emphasis on both treatment-naïve and relapsed/refractory disease settings.
- Novel agent combinations with rituximab
- Targeted therapy development
- Evaluation of tazemetostat combinations
Research focuses on innovative treatment approaches including ibrutinib, odronextamab, and combination therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.